USA Self-monitoring Blood Glucose System Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Self-monitoring Blood Glucose System market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Self-monitoring Blood Glucose System market. Detailed analysis of key players, along with key growth strategies adopted by Self-monitoring Blood Glucose System industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Abbott (US)

    • Roche (Switzerland)

    • Prodigy Diabetes Care (US)

    • LifeScan (US)

    • Medtronic (Ireland), Dexcom (US)

    • Ascensia (Switzerland)

    • ACON Laboratories (US)

    • Ypsomed (Switzerland)

    • Nova Biomedical (US)

    • ARKRAY (Japan)

    • B Braun (Germany)

    • Nipro (Japan), Sanofi (France)

    By Type:

    • Blood Glucose meters

    • Testing strips

    • Lancets & Lancing Devices

    By End-User:

    • Type 2 Diabetes

    • Type 1 Diabetes

    • Gestational Diabetes

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Self-monitoring Blood Glucose System Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Self-monitoring Blood Glucose System Market Size and Growth Rate of Blood Glucose meters from 2016 to 2027

      • 1.3.2 USA Self-monitoring Blood Glucose System Market Size and Growth Rate of Testing strips from 2016 to 2027

      • 1.3.3 USA Self-monitoring Blood Glucose System Market Size and Growth Rate of Lancets & Lancing Devices from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Self-monitoring Blood Glucose System Market Size and Growth Rate of Type 2 Diabetes from 2016 to 2027

      • 1.4.2 USA Self-monitoring Blood Glucose System Market Size and Growth Rate of Type 1 Diabetes from 2016 to 2027

      • 1.4.3 USA Self-monitoring Blood Glucose System Market Size and Growth Rate of Gestational Diabetes from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Self-monitoring Blood Glucose System Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Self-monitoring Blood Glucose System Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Self-monitoring Blood Glucose System Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Self-monitoring Blood Glucose System Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Self-monitoring Blood Glucose System Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Self-monitoring Blood Glucose System by Major Types

      • 3.4.1 Market Size and Growth Rate of Blood Glucose meters

      • 3.4.2 Market Size and Growth Rate of Testing strips

      • 3.4.3 Market Size and Growth Rate of Lancets & Lancing Devices

    4 Segmentation of Self-monitoring Blood Glucose System Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Self-monitoring Blood Glucose System by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Self-monitoring Blood Glucose System in Type 2 Diabetes

      • 4.4.2 Market Size and Growth Rate of Self-monitoring Blood Glucose System in Type 1 Diabetes

      • 4.4.3 Market Size and Growth Rate of Self-monitoring Blood Glucose System in Gestational Diabetes

    5 Market Analysis by Regions

    • 5.1 USA Self-monitoring Blood Glucose System Production Analysis by Regions

    • 5.2 USA Self-monitoring Blood Glucose System Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Self-monitoring Blood Glucose System Landscape Analysis

    • 6.1 West USA Self-monitoring Blood Glucose System Landscape Analysis by Major Types

    • 6.2 West USA Self-monitoring Blood Glucose System Landscape Analysis by Major End-Users

    7 South USA Self-monitoring Blood Glucose System Landscape Analysis

    • 7.1 South USA Self-monitoring Blood Glucose System Landscape Analysis by Major Types

    • 7.2 South USA Self-monitoring Blood Glucose System Landscape Analysis by Major End-Users

    8 Middle West USA Self-monitoring Blood Glucose System Landscape Analysis

    • 8.1 Middle West USA Self-monitoring Blood Glucose System Landscape Analysis by Major Types

    • 8.2 Middle West USA Self-monitoring Blood Glucose System Landscape Analysis by Major End-Users

    9 Northeast USA Self-monitoring Blood Glucose System Landscape Analysis

    • 9.1 Northeast USA Self-monitoring Blood Glucose System Landscape Analysis by Major Types

    • 9.2 Northeast USA Self-monitoring Blood Glucose System Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Abbott (US)

        • 10.1.1 Abbott (US) Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Roche (Switzerland)

        • 10.2.1 Roche (Switzerland) Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Prodigy Diabetes Care (US)

        • 10.3.1 Prodigy Diabetes Care (US) Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 LifeScan (US)

        • 10.4.1 LifeScan (US) Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Medtronic (Ireland), Dexcom (US)

        • 10.5.1 Medtronic (Ireland), Dexcom (US) Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Ascensia (Switzerland)

        • 10.6.1 Ascensia (Switzerland) Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 ACON Laboratories (US)

        • 10.7.1 ACON Laboratories (US) Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Ypsomed (Switzerland)

        • 10.8.1 Ypsomed (Switzerland) Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Nova Biomedical (US)

        • 10.9.1 Nova Biomedical (US) Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 ARKRAY (Japan)

        • 10.10.1 ARKRAY (Japan) Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

      • 10.11 B Braun (Germany)

        • 10.11.1 B Braun (Germany) Company Profile and Recent Development

        • 10.11.2 Market Performance

        • 10.11.3 Product and Service Introduction

      • 10.12 Nipro (Japan), Sanofi (France)

        • 10.12.1 Nipro (Japan), Sanofi (France) Company Profile and Recent Development

        • 10.12.2 Market Performance

        • 10.12.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Self-monitoring Blood Glucose System Market Size and Growth Rate of Blood Glucose meters from 2016 to 2027

    • Figure USA Self-monitoring Blood Glucose System Market Size and Growth Rate of Testing strips from 2016 to 2027

    • Figure USA Self-monitoring Blood Glucose System Market Size and Growth Rate of Lancets & Lancing Devices from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Self-monitoring Blood Glucose System Market Size and Growth Rate of Type 2 Diabetes from 2016 to 2027

    • Figure USA Self-monitoring Blood Glucose System Market Size and Growth Rate of Type 1 Diabetes from 2016 to 2027

    • Figure USA Self-monitoring Blood Glucose System Market Size and Growth Rate of Gestational Diabetes from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Self-monitoring Blood Glucose System Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Self-monitoring Blood Glucose System Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Self-monitoring Blood Glucose System Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Self-monitoring Blood Glucose System Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Self-monitoring Blood Glucose System Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Self-monitoring Blood Glucose System

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Self-monitoring Blood Glucose System by Different Types from 2016 to 2027

    • Table Consumption Share of Self-monitoring Blood Glucose System by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Blood Glucose meters

    • Figure Market Size and Growth Rate of Testing strips

    • Figure Market Size and Growth Rate of Lancets & Lancing Devices

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Self-monitoring Blood Glucose System by Different End-Users from 2016 to 2027

    • Table Consumption Share of Self-monitoring Blood Glucose System by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Type 2 Diabetes

    • Figure Market Size and Growth Rate of Type 1 Diabetes

    • Figure Market Size and Growth Rate of Gestational Diabetes

    • Table USA Self-monitoring Blood Glucose System Production by Regions

    • Table USA Self-monitoring Blood Glucose System Production Share by Regions

    • Figure USA Self-monitoring Blood Glucose System Production Share by Regions in 2016

    • Figure USA Self-monitoring Blood Glucose System Production Share by Regions in 2021

    • Figure USA Self-monitoring Blood Glucose System Production Share by Regions in 2027

    • Table USA Self-monitoring Blood Glucose System Consumption by Regions

    • Table USA Self-monitoring Blood Glucose System Consumption Share by Regions

    • Figure USA Self-monitoring Blood Glucose System Consumption Share by Regions in 2016

    • Figure USA Self-monitoring Blood Glucose System Consumption Share by Regions in 2021

    • Figure USA Self-monitoring Blood Glucose System Consumption Share by Regions in 2027

    • Table West USA Self-monitoring Blood Glucose System Consumption by Types from 2016 to 2027

    • Table West USA Self-monitoring Blood Glucose System Consumption Share by Types from 2016 to 2027

    • Figure West USA Self-monitoring Blood Glucose System Consumption Share by Types in 2016

    • Figure West USA Self-monitoring Blood Glucose System Consumption Share by Types in 2021

    • Figure West USA Self-monitoring Blood Glucose System Consumption Share by Types in 2027

    • Table West USA Self-monitoring Blood Glucose System Consumption by End-Users from 2016 to 2027

    • Table West USA Self-monitoring Blood Glucose System Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Self-monitoring Blood Glucose System Consumption Share by End-Users in 2016

    • Figure West USA Self-monitoring Blood Glucose System Consumption Share by End-Users in 2021

    • Figure West USA Self-monitoring Blood Glucose System Consumption Share by End-Users in 2027

    • Table South USA Self-monitoring Blood Glucose System Consumption by Types from 2016 to 2027

    • Table South USA Self-monitoring Blood Glucose System Consumption Share by Types from 2016 to 2027

    • Figure South USA Self-monitoring Blood Glucose System Consumption Share by Types in 2016

    • Figure South USA Self-monitoring Blood Glucose System Consumption Share by Types in 2021

    • Figure South USA Self-monitoring Blood Glucose System Consumption Share by Types in 2027

    • Table South USA Self-monitoring Blood Glucose System Consumption by End-Users from 2016 to 2027

    • Table South USA Self-monitoring Blood Glucose System Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Self-monitoring Blood Glucose System Consumption Share by End-Users in 2016

    • Figure South USA Self-monitoring Blood Glucose System Consumption Share by End-Users in 2021

    • Figure South USA Self-monitoring Blood Glucose System Consumption Share by End-Users in 2027

    • Table Middle West USA Self-monitoring Blood Glucose System Consumption by Types from 2016 to 2027

    • Table Middle West USA Self-monitoring Blood Glucose System Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Self-monitoring Blood Glucose System Consumption Share by Types in 2016

    • Figure Middle West USA Self-monitoring Blood Glucose System Consumption Share by Types in 2021

    • Figure Middle West USA Self-monitoring Blood Glucose System Consumption Share by Types in 2027

    • Table Middle West USA Self-monitoring Blood Glucose System Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Self-monitoring Blood Glucose System Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Self-monitoring Blood Glucose System Consumption Share by End-Users in 2016

    • Figure Middle West USA Self-monitoring Blood Glucose System Consumption Share by End-Users in 2021

    • Figure Middle West USA Self-monitoring Blood Glucose System Consumption Share by End-Users in 2027

    • Table Northeast USA Self-monitoring Blood Glucose System Consumption by Types from 2016 to 2027

    • Table Northeast USA Self-monitoring Blood Glucose System Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Self-monitoring Blood Glucose System Consumption Share by Types in 2016

    • Figure Northeast USA Self-monitoring Blood Glucose System Consumption Share by Types in 2021

    • Figure Northeast USA Self-monitoring Blood Glucose System Consumption Share by Types in 2027

    • Table Northeast USA Self-monitoring Blood Glucose System Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Self-monitoring Blood Glucose System Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Self-monitoring Blood Glucose System Consumption Share by End-Users in 2016

    • Figure Northeast USA Self-monitoring Blood Glucose System Consumption Share by End-Users in 2021

    • Figure Northeast USA Self-monitoring Blood Glucose System Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Abbott (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott (US)

    • Figure Sales and Growth Rate Analysis of Abbott (US)

    • Figure Revenue and Market Share Analysis of Abbott (US)

    • Table Product and Service Introduction of Abbott (US)

    • Table Company Profile and Development Status of Roche (Switzerland)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche (Switzerland)

    • Figure Sales and Growth Rate Analysis of Roche (Switzerland)

    • Figure Revenue and Market Share Analysis of Roche (Switzerland)

    • Table Product and Service Introduction of Roche (Switzerland)

    • Table Company Profile and Development Status of Prodigy Diabetes Care (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Prodigy Diabetes Care (US)

    • Figure Sales and Growth Rate Analysis of Prodigy Diabetes Care (US)

    • Figure Revenue and Market Share Analysis of Prodigy Diabetes Care (US)

    • Table Product and Service Introduction of Prodigy Diabetes Care (US)

    • Table Company Profile and Development Status of LifeScan (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of LifeScan (US)

    • Figure Sales and Growth Rate Analysis of LifeScan (US)

    • Figure Revenue and Market Share Analysis of LifeScan (US)

    • Table Product and Service Introduction of LifeScan (US)

    • Table Company Profile and Development Status of Medtronic (Ireland), Dexcom (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Medtronic (Ireland), Dexcom (US)

    • Figure Sales and Growth Rate Analysis of Medtronic (Ireland), Dexcom (US)

    • Figure Revenue and Market Share Analysis of Medtronic (Ireland), Dexcom (US)

    • Table Product and Service Introduction of Medtronic (Ireland), Dexcom (US)

    • Table Company Profile and Development Status of Ascensia (Switzerland)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ascensia (Switzerland)

    • Figure Sales and Growth Rate Analysis of Ascensia (Switzerland)

    • Figure Revenue and Market Share Analysis of Ascensia (Switzerland)

    • Table Product and Service Introduction of Ascensia (Switzerland)

    • Table Company Profile and Development Status of ACON Laboratories (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ACON Laboratories (US)

    • Figure Sales and Growth Rate Analysis of ACON Laboratories (US)

    • Figure Revenue and Market Share Analysis of ACON Laboratories (US)

    • Table Product and Service Introduction of ACON Laboratories (US)

    • Table Company Profile and Development Status of Ypsomed (Switzerland)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ypsomed (Switzerland)

    • Figure Sales and Growth Rate Analysis of Ypsomed (Switzerland)

    • Figure Revenue and Market Share Analysis of Ypsomed (Switzerland)

    • Table Product and Service Introduction of Ypsomed (Switzerland)

    • Table Company Profile and Development Status of Nova Biomedical (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nova Biomedical (US)

    • Figure Sales and Growth Rate Analysis of Nova Biomedical (US)

    • Figure Revenue and Market Share Analysis of Nova Biomedical (US)

    • Table Product and Service Introduction of Nova Biomedical (US)

    • Table Company Profile and Development Status of ARKRAY (Japan)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ARKRAY (Japan)

    • Figure Sales and Growth Rate Analysis of ARKRAY (Japan)

    • Figure Revenue and Market Share Analysis of ARKRAY (Japan)

    • Table Product and Service Introduction of ARKRAY (Japan)

    • Table Company Profile and Development Status of B Braun (Germany)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of B Braun (Germany)

    • Figure Sales and Growth Rate Analysis of B Braun (Germany)

    • Figure Revenue and Market Share Analysis of B Braun (Germany)

    • Table Product and Service Introduction of B Braun (Germany)

    • Table Company Profile and Development Status of Nipro (Japan), Sanofi (France)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nipro (Japan), Sanofi (France)

    • Figure Sales and Growth Rate Analysis of Nipro (Japan), Sanofi (France)

    • Figure Revenue and Market Share Analysis of Nipro (Japan), Sanofi (France)

    • Table Product and Service Introduction of Nipro (Japan), Sanofi (France)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.